A detailed history of Fmr LLC transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Fmr LLC holds 6 shares of RMTI stock, worth $5. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Holding current value
$5
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$0.8 - $1.81 $4 - $10
6 New
6 $0
Q1 2025

May 12, 2025

SELL
$1.13 - $2.33 $56 - $116
-50 Reduced 55.56%
40 $0
Q4 2024

Feb 13, 2025

BUY
$2.01 - $4.65 $180 - $418
90 New
90 $0
Q4 2022

Feb 13, 2023

SELL
$0.84 - $1.39 $294 - $487
-351 Reduced 25.94%
1,002 $1,000
Q3 2022

Nov 10, 2022

BUY
$1.2 - $2.11 $1,623 - $2,854
1,353 New
1,353 $2,000

Others Institutions Holding RMTI

About ROCKWELL MEDICAL, INC.


  • Ticker RMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 10,675,200
  • Market Cap $9.93M
  • Description
  • Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...
More about RMTI
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.